Surgical Technique for Metastatic Brain Tumors by Takeshi Okuda & Amami Kato
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Surgical Technique for Metastatic Brain Tumors 
Takeshi Okuda and Amami Kato 
Department of Neurosurgery, Kinki University School of Medicine,Osaka,  
Japan 
1. Introduction 
In recent years, more effective therapies for cancer, especially systemic chemotherapy 
regimens, have been developed, and there has been striking improvement in the life 
expectancy of patients with advanced cancer. However, the benefit from systemic 
chemotherapy is limited in the case of brain metastases and, conversely, the recent 
prolongation of the life expectancy of many patients with advanced cancer has translated 
into a trend for an increase in brain metastases. It can thus be anticipated that there will be 
an even further increase in the importance of cancer therapy for brain metastases. The main 
treatment approaches for brain metastases are radiotherapy and surgical resection. 
Postoperative whole-brain irradiation is a standard therapeutic procedure for metastatic 
brain tumors. However, local recurrence rates of 10% to 30% have been reported even with 
concomitant whole-brain irradiation (Patchell et al. 1990; Schackert et al. 2001; Shinoura et 
al. 2002). In addition, late complications of whole-brain irradiation can greatly affect quality 
of life in patients (DeAngelis et al. 1989). On the other hand, with regard to surgical 
resection, the development of surgical devices, such as neuro-navigation systems and 
intraoperative monitoring, has resulted in dramatic improvements in safety and reliability 
(Black and Johnson 2004). However, with regard to improvement in the surgical technique 
itself, there has only been the recommendation for performance ofｗen bloc resection 
including a surgical margin of about 5 mmｘ(Modha et al. 2005), and there have been hardly 
any innovations, even when compared with the case of malignant glioma surgery. Thus, at 
first glance, it would seem that metastatic brain tumor surgery has been established. 
However, in fact, the local recurrence rate is high in the case of surgical resection alone, and 
attempts are being made to improve the local recurrence rate by performing follow-up 
treatments such as whole-brain irradiation, stereotactic radiosurgery on the resection cavity, 
or local chemotherapy (Sills 2005; Kim et al. 2006; Mathieu et al. 2006; Ewend et al. 2007; 
Ranasinghe and Sheehan 2007). The high local recurrence rate following surgical resection 
alone clearly implies the presence of residual tumor tissue (Patchell et al. 1998). On the basis 
of this background, we have been trying various modifications of the surgical technique for 
surgical resection of metastatic brain tumors to improve the resection rate and the local 
recurrence rate. Our modifications are explained below. 
2. Surgical technique 
2.1 Metastatic brain tumor surgery using fluorescein sodium 
Fluorescein sodium (Alcon Japan Co., Ltd., Tokyo, Japan) is a tracer of blood-brain barrier 
disruption, and enhanceable tumors are stained yellow. Fluorescein sodium is extensively 
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used in ophthalmology, and its safety has been established. The operative technique of 
using fluorescein sodium has a long history of use during brain tumor surgery, as reported 
by Moore and Murray (Moore et al. 1948; Murray 1982). A special type of filter must be 
provided to observe the fluorescence, but Shinoda et al. reported that observation via a 
normal microscope under white light without using a special type of filter was also possible 
by intravenously injecting a double dose (20 mg/kg) in glioma surgery (Shinoda et al. 2003). 
We applied this technique to metastatic brain tumor surgery (Okuda et al. 2007). After 
induction of general anesthesia, and the dura is opened, fluorescein sodium (20 mg/kg) is 
injected intravenously. Tumor resection is performed >10 minutes after injection of 
fluorescein sodium. A yellow-stained tumor is visible under the white light of a normal 
microscope without a filter. The resected tumor using fluorescein sodium and the schematic 
diagram are shown in Figure 1.  
 
 
Fig. 1. Cut surface of the resected metastatic brain tumor from primary breast cancer and the 
schematic diagram. 
The tumor parenchyma is stained, and the gliosis portion remains around the tumor. As 
shown in the diagram, the surrounding gliosis portion is aspirated and resected while 
carefully confirming the stained tumor. The edematous portion surrounding the tumor is 
also slightly stained, but it is easy to identify the boundary, and ideal en bloc resection can 
be achieved while confirming the stained tumor. 
Two cases are presented below.  
Case 1 was a patient with left frontal lobe metastasis from primary lung cancer (Fig. 2A). Prior 
to injection of fluorescein sodium (Fig. 3A), the tumor could not be distinguished from the 
brain surface. After injection (Fig. 3B), the yellow-stained tumor could be distinguished from 
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the brain surface. Under magnification, the border was clearly discernable (Fig. 3C). The 
border of the white-colored gliosis could also be discerned (Fig. 3D), and en bloc resection was 
performed while performing suction and dissection (Fig. 3E). The resection cavity is shown 
(Fig. 3F). Postoperative MRI shows that complete resection was achieved (Fig. 2B). 
 
 
Fig. 2. MRI findings for Case 1 (A)Preoperative enhanced T1-weighted image showing a 
metastatic brain tumor in the left frontal lobe. (B) Enhanced  T1-weighted image 1 day after 
surgery showing no residual tumor. 
 
 
Fig. 3. Intraoperative photographs of Case 1 (A) The brain surface prior to fluorescein 
sodium injection. (B) The brain surface following fluorescein sodium injection. The yellow-
stained tumor can be seen. (C) Magnification of B. (D) The border with the surrounding 
gliosis portion. (E) En bloc resection. (F) Resection cavity. 
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Case 2 was a patient with left frontal lobe metastasis from primary renal cell carcinoma (Fig. 
4A). The tumor was located in the speech area. Fluorescein sodium was injected 
intravenously, the tumor was approached through minimal corticotomy, and the yellow-
stained tumor surface was confirmed (Fig. 5A, B). En bloc resection was performed (Fig. 5C). 
Postoperatively, the aphasia symptoms improved, and MRI confirmed that complete 
resection had been achieved (Fig. 4B). Accordingly, even in cases of brain tumors located in 
eloquent areas, such as not only the speech area but also the motor area, use of fluorescein 




Fig. 4. MRI findings for Case 2 (A) Preoperative enhanced T1-weighted image showing a 
metastatic brain tumor in the left temporal lobe. (B) Enhanced T1-weighted image 1 day 




Fig. 5. Intraoperative photographs of Case 2 (A) The tumor surface has been approached, 
and yellow staining of the tumor by the injected fluorescein sodium is evident. (B) 
Dissection of the tumor. (C) The tumor was removed by en bloc resection. 
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To date, we have used fluorescein sodium in more than 100 patients to facilitate surgical 
resection of metastatic brain tumors, and there have been absolutely no instances of 
permanent adverse reactions. Anaphylactic shock has been reported as a serious side effect, 
but it is rare (Tanahashi et al. 2006) and was not observed in our study. As transient adverse 
events, we have seen yellow staining of the skin, mucosa, and urine, but all cases resolved 
within 24 hours. This technique will contribute to increasing the resection rate in metastatic 
brain tumor surgery. Our data also showed statistically significant improvement in the local 
recurrence rate. Our fluorescence-guided surgery achieved successful local control rates of 
metastatic brain tumors in 80% of patients without whole-brain irradiation (Okuda et al. 
2010). Conversely, previous reports of conventional surgery have yielded successful local 
control rates of only 54% to 64% under similar conditions (Patchell et al. 1998; Schackert et 
al. 2001). Although these results are only a guide, based on results from very few patients, 
fluorescence-guided surgery might enable avoidance or postponement of subsequent 
whole-brain irradiation, which will not only increase quality of life for patients, but also 
keeps whole-brain irradiation as a therapeutic option for subsequent brain metastases. This 
may help to prolong survival and decrease the rate of central nervous system death. This 
technique is simple, inexpensive, and does not require any special equipment. We are 
confident that it will be recognized as an important surgical innovation for application to the 
field of metastatic brain tumor surgery. 
2.2 Surgical technique for a cystic-type metastatic brain tumor: transformation to a 
solid-type tumor using hydrofiber dressing 
Cystic-type metastatic brain tumors may have injury to the wall during surgery, which can in 
some cases result in incomplete tumor resection and dissemination of cancer cells in cyst fluid 
(Nakagawa et al. 1992). By transforming cystic-type tumors to solid-type tumors, we 
developed a surgical technique that makes it possible to carry out an ideal en bloc resection 
(Okuda et al. 2009). In this method, we insert a hydrofiber dressing (Aquacel; Convatec, 
London, UK) into a cyst, thereby transforming it to a solid-type tumor. Hydrofiber dressing is 
a coating agent with a high fluid-absorptive capacity that was originally used as a dressing for 
exudative wounds (Armstrong and Ruckley 1997). Hydrofiber dressing is a sodium 
carboxymethylcellulose hydrocolloid polymer with fluid-absorptive capacity equal to 25 times 
its own weight. This material also has a high capacity to retain absorbed water (Fig. 6). 
 
 
Fig. 6. Images of hydrofiber dressing (A) Hydrofiber dressing can be cut into various sizes. 
(B) The dotted line shows hydrofiber dressing filled with physiologic saline. 
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The hydrofiber dressing converts into a gel upon absorption of water, and it integrates with 
the tumor. As a result, the tumor becomes a soft, solid-type tumor. A flow diagram of the 







Fig. 7. Schema of cystic-type metastatic brain tumor surgery using hydrofiber dressing(A) 
Cystic-type tumor before use of hydrofiber dressing. (B) Suctioning of fluid in the cyst. (C, 
D) Hydrofiber dressing was inserted in the cyst cavity. (E) Injection of physiologic saline. F: 
The hydrofiber dressing absorbs the fluid in the cyst cavity and fills the cyst, thereby, 
transforming the tumor into a small solid-type, tumor. 
This method converted the cystic-type tumor into a solid-type, small-size tumor, and ideal 
en bloc resection could be performed. In addition, the hydrofiber dressing absorbs the fluid 
contents remaining inside the cyst, and by retaining that fluid, it helps prevent tumor cell 
dissemination during the operation. 
A case is presented below. 
The patient had a right occipital lobe metastasis of a squamous cell carcinoma (Fig. 8A). 
First, the cyst was opened for aspiration of fluid (Fig. 9A, B). A small cut was made on the 
tumor surface to aspirate the fluid contents of the cyst (Fig. 9C), and then hydrofiber 
dressing was inserted into the cyst (Fig. 9D). Physiologic saline was then injected to fill the 
cyst (Fig. 9E). En bloc resection was performed (Fig. 9F), and postoperative MRI revealed no 
residual tumor (Fig. 8B). The tumor that was actually removed by en bloc resection is shown 
in Figure 10. 
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Fig. 8. MRI findings for representative case using hydrofiber dressing (A) Preoperative 
enhanced T1-weighted image showing a metastatic brain tumor in the right occipital lobe. 
(B) Enhanced T1-weighted image 1 day after surgery showing no residual tumor. 
 
 
Fig. 9. Intraoperative photographs of representative case using hydrofiber dressing (A) 
Aspirating of the fluid contents of the cyst. (B) Fluid contents of the cyst. (C) Cyst cavity. (D) 
Insertion of the hydrofiber dressing. (E) Injection of physiological saline. (F) En bloc 
resection. 
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Fig. 10. The resected tumor using hydrofiber dressing (A) The black arrow indicates the 
opening through which the hydrofiber dressing was inserted. (B) When the cyst wall was 
incised, it could be seen that the hydrofiber dressing had become a gel inside the cyst. 
Hydrofiber dressing is available in a blister pack that has been sterilized by irradiation. 
Numerous clinical trials for human wounds have confirmed the safety of hydrofiber 
dressing, and Hoekstra et al. observed few histologic reactions in rats in an examination of 
the biologic effects of hydrofiber dressing (Hoekstra et al. 2002). There were no adverse 
events in the 12 patients in our study, and the safety of the method we used is likely to be 
high, because hydrofiber dressing is used in the cyst without direct contact with brain 
tissue. Application of this technique to cases of cystic-type metastatic brain tumors makes it 
possible to perform ideal en bloc resection of the tumor. In addition, it is easy to perform 
and inexpensive, and we believe that it will prove similarly useful in surgical resection of 
other cystic brain tumors. 
3. Conclusion 
We have described two surgical innovations for metastatic brain tumors. Brain metastases 
cause serious problems in terms of the quality of life and prognosis of cancer patients. 
Surgery for metastatic brain tumors can have both good and bad sequelae. The surgical 
techniques we have described are both easy and safe, and they increase the resection rate 
while improving the local recurrence rate. As a result, we think that these methods will have 
great benefit to patients by helping avoid and/or delay radiotherapy, while also improving 
the clinical symptoms. 
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